AU1454599A - Compounds inhibiting cd4-gp120 interaction and uses thereof - Google Patents

Compounds inhibiting cd4-gp120 interaction and uses thereof

Info

Publication number: AU1454599A
Authority: AU; Australia
Prior art keywords: interaction; compounds inhibiting; inhibiting; compounds
Prior art date: 1997-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU14545/99A

Inventor

Wayne A. Hendrickson

Peter D. Kwong

James M. Samanen

Joseph G Sodroski

Richard T. Wyatt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Columbia University in the City of New York

Dana Farber Cancer Institute Inc

SmithKline Beecham Corp

Original Assignee

Columbia University in the City of New York

Dana Farber Cancer Institute Inc

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-10

Filing date

1998-11-10

Publication date

1999-05-31

1998-11-10 Application filed by Columbia University in the City of New York, Dana Farber Cancer Institute Inc, SmithKline Beecham Corp filed Critical Columbia University in the City of New York

1999-05-31 Publication of AU1454599A publication Critical patent/AU1454599A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU14545/99A 1997-11-10 1998-11-10 Compounds inhibiting cd4-gp120 interaction and uses thereof Abandoned AU1454599A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US96770897A	1997-11-10	1997-11-10
US08967708		1997-11-10
US10076498A	1998-06-18	1998-06-18
US09100764		1998-06-18
PCT/US1998/023906 WO1999024065A1 (en)	1997-11-10	1998-11-10	COMPOUNDS INHIBITING CD4-gp120 INTERACTION AND USES THEREOF

Publications (1)

Publication Number	Publication Date
AU1454599A true AU1454599A (en)	1999-05-31

Family

ID=26797520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU14545/99A Abandoned AU1454599A (en)	1997-11-10	1998-11-10	Compounds inhibiting cd4-gp120 interaction and uses thereof

Country Status (2)

Country	Link
AU (1)	AU1454599A (en)
WO (1)	WO1999024065A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6743594B1 (en)	1995-06-06	2004-06-01	Human Genome Sciences, Inc.	Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en)	1995-06-06	2000-02-15	Human Genome Sciences, Inc.	Polynucleotides encoding human G-protein chemokine receptor HDGNR10
US7175988B2 (en)	2001-02-09	2007-02-13	Human Genome Sciences, Inc.	Human G-protein Chemokine Receptor (CCR5) HDGNR10
US7393934B2 (en)	2001-12-21	2008-07-01	Human Genome Sciences, Inc.	Human G-protein chemokine receptor (CCR5) HDGNR10
JP2008507255A (en)	2004-03-12	2008-03-13	ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド	Human G protein chemokine receptor (CCR5) HDGNR10
US20060100432A1 (en)	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en)	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en)	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
US9776963B2 (en)	2008-11-10	2017-10-03	The Trustees Of The University Of Pennsylvania	Small molecule CD4 mimetics and uses thereof
WO2011024175A1 (en)	2009-08-28	2011-03-03	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection
EP2480572B1 (en)	2009-09-25	2019-01-30	The United States of America, as represented by The Secretary, Department of Health and Human Services	Neutralizing antibodies to hiv-1 and their use
US9695230B2 (en)	2011-12-08	2017-07-04	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
WO2013090696A1 (en)	2011-12-14	2013-06-20	Dana-Farber Cancer Institute, Inc.	Cd4-mimetic inhibitors of hiv-1 entry and methods of use thereof
US9341639B2 (en)	2013-07-26	2016-05-17	Industrial Technology Research Institute	Apparatus for microfluid detection
WO2016025681A1 (en)	2014-08-13	2016-02-18	The Trustees Of The University Of Pennsylvania	Inhibitors of hiv-1 entry and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5109123A (en) *	1988-06-14	1992-04-28	Dana Farber Cancer Institute	Alteration of ability of soluble CD4 fragments to bind HIV
US5716826A (en) *	1988-03-21	1998-02-10	Chiron Viagene, Inc.	Recombinant retroviruses
US5614612A (en) *	1990-03-09	1997-03-25	Haigwood; Nancy L.	Purified gp120 compositions retaining natural conformation

1998
- 1998-11-10 WO PCT/US1998/023906 patent/WO1999024065A1/en not_active Ceased
- 1998-11-10 AU AU14545/99A patent/AU1454599A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999024065A1 (en)	1999-05-20

Publication	Publication Date	Title
AU9790198A (en)	1999-04-27	Compounds and methods
AU8127998A (en)	1999-02-08	Quinoline compounds and medicinal uses thereof
AU5636498A (en)	1998-09-03	Pesticide composition
AU8865098A (en)	1999-03-16	A composition and a product containing the same
AU9781998A (en)	1999-04-12	Huchordin and uses thereof
AU4198299A (en)	1999-12-06	Compounds and uses thereof
AU1454599A (en)	1999-05-31	Compounds inhibiting cd4-gp120 interaction and uses thereof
AU6747798A (en)	1999-06-15	Hexanitrohexaazaisowurtzitane composition and explosive composition containing said composition
AU6827898A (en)	1998-09-29	Detergent-package combination
AU1277799A (en)	1999-07-12	Polycyclic alpha-amino-$m(e)-caprolactams and related compounds
AUPP433398A0 (en)	1998-07-16	Compounds and processes
AU5953598A (en)	1998-10-01	Plaque-inhibiting composites
AU2701799A (en)	1999-04-27	Computers
AU3866897A (en)	1998-03-06	Diamide compounds and drugs containing the same
AU8695298A (en)	1999-03-01	Compounds and uses thereof
AU2333099A (en)	1999-10-18	Aryloxyanilides and related compounds
AU6119398A (en)	1998-09-22	Phenylpropenone compounds and medicines containing the same
AU7163198A (en)	1998-11-24	Retinoid-like compounds
AU9179098A (en)	1999-04-23	Security devices
AU8693198A (en)	1999-03-01	Compounds and uses thereof
AU9457798A (en)	1999-05-03	Chromone compounds and use thereof
AU5533898A (en)	1998-08-20	Cork-based protected stopper
ZA988492B (en)	1999-03-31	Substituted tetrahydro-naphthalenes and analogous compounds
AU7151498A (en)	1998-11-13	Neuroprotective compounds and uses thereof
AU1616600A (en)	2000-05-29	Aminobenzisoxazole compounds and libraries thereof

Legal Events

Date	Code	Title	Description
2000-07-27	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase